Vinva Investment Management Ltd Acquires 5,242 Shares of CVS Health Co. (NYSE:CVS)

Vinva Investment Management Ltd increased its holdings in shares of CVS Health Co. (NYSE:CVS) by 10.2% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 56,446 shares of the pharmacy operator’s stock after buying an additional 5,242 shares during the period. Vinva Investment Management Ltd’s holdings in CVS Health were worth $3,465,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. MidAtlantic Capital Management Inc. bought a new stake in CVS Health in the third quarter valued at approximately $25,000. Livelsberger Financial Advisory bought a new stake in CVS Health in the third quarter valued at approximately $31,000. Reston Wealth Management LLC bought a new stake in CVS Health in the third quarter valued at approximately $32,000. First Community Trust NA increased its stake in CVS Health by 116.2% in the second quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock valued at $33,000 after purchasing an additional 302 shares in the last quarter. Finally, Kathleen S. Wright Associates Inc. bought a new stake in CVS Health in the third quarter valued at approximately $33,000. Institutional investors own 80.66% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the stock. StockNews.com cut shares of CVS Health from a “hold” rating to a “sell” rating in a report on Thursday, November 14th. Mizuho reduced their price target on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a report on Thursday, October 24th. Royal Bank of Canada reduced their price target on shares of CVS Health from $68.00 to $58.00 and set an “outperform” rating for the company in a report on Friday, November 15th. Truist Financial reiterated a “buy” rating and issued a $67.00 price target (down previously from $76.00) on shares of CVS Health in a report on Wednesday, November 20th. Finally, UBS Group upped their price target on shares of CVS Health from $60.00 to $62.00 and gave the company a “neutral” rating in a report on Thursday, November 7th. One research analyst has rated the stock with a sell rating, seven have given a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat.com, CVS Health has a consensus rating of “Moderate Buy” and a consensus target price of $70.33.

CVS Health Stock Performance

NYSE CVS opened at $59.96 on Friday. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. The firm’s fifty day moving average price is $59.33 and its two-hundred day moving average price is $58.73. CVS Health Co. has a 1 year low of $52.71 and a 1 year high of $83.25. The firm has a market capitalization of $75.45 billion, a P/E ratio of 15.22, a price-to-earnings-growth ratio of 1.02 and a beta of 0.55.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.08 by $0.01. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The firm had revenue of $95.43 billion for the quarter, compared to analyst estimates of $92.72 billion. During the same period in the prior year, the firm posted $2.21 earnings per share. The company’s quarterly revenue was up 6.3% compared to the same quarter last year. As a group, research analysts anticipate that CVS Health Co. will post 5.37 EPS for the current year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Monday, October 21st were given a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 4.44%. The ex-dividend date was Monday, October 21st. CVS Health’s payout ratio is presently 67.51%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.